Cite
HARVARD Citation
Cheng, E. et al. (2017). Residual Pure Intralymphatic Breast Carcinoma Following Neoadjuvant Chemotherapy Is Indicative of Poor Clinical Outcome, Even in Node-Negative Patients. American journal of surgical pathology. p. . [Online].